4.5 Article

Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls

期刊

NEUROBIOLOGY OF AGING
卷 59, 期 -, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2017.07.001

关键词

SORL1; ABCA7; TREM2; Alzheimer's disease

资金

  1. Clinical Research Hospital Program from French Ministry of Health (GMAJ, PHRC) [2008/067]
  2. CNR-MAJ
  3. JPND PERADES
  4. GENMED labex
  5. FP7 AgedBrainSysBio
  6. France Genomique National infrastructure
  7. Agence Nationale pour la Recherche [ANR-10-INBS-09]
  8. Centre National de Genotypage
  9. National Foundation for Alzheimer's disease and related disorders
  10. Institut Pasteur de Lille, Inserm, FRC (Fondation pour la Recherche sur le Cerveau)
  11. Lille Metropole Communaute Urbaine council
  12. French government's LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease)

向作者/读者索取更多资源

We performed whole-exome and whole-genome sequencing in 927 late-onset Alzheimer disease (LOAD) cases, 852 early-onset AD (EOAD) cases, and 1273 controls from France. We assessed the evidence for gene-based association of rare variants with AD in 6 genes for which an association with such variants was previously claimed. When aggregating protein-truncating and missensepredicted damaging variants, we found exome-wide significant association between EOAD risk and rare variants in SORL1, TREM2, and ABCA7. No exome-wide significant signal was obtained in the LOAD sample, and significance of the order of 10(-6) was observed in the whole AD group for TREM2. Our study confirms previous gene-level results for TREM2, SORL1, and ABCA7 and provides a clearer insight into the classes of rare variants involved. Despite different effect sizes and varying cumulative minor allele frequencies, the rare protein-truncating and missense-predicted damaging variants in TREM2, SORL1, and ABCA7 contribute similarly to the heritability of EOAD and explain between 1.1% and 1.5% of EOAD heritability each, compared with 9.12% for APOE epsilon 4. (C) 2017 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据